Medical Device News Magazine

MicroPort Orthopedics Receives Long-Term ODEP Rating for its Advance® Medial-Pivot Knee System

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

MicroPort Orthopedics, a global leader in orthopedic devices and technologies, has received a “15A” rating for its Advance® Medial-Pivot knee system from the Orthopaedic Data Evaluation Panel (ODEP).

Fifteen (15) years is the longest benchmark that ODEP assigns ratings for knee implants, providing further evidence of the long clinical heritage of the Advance® Medial-Pivot knee system. ODEP was established in 2002, and provides an independent review of clinical data to assign ratings and share information about the success of arthroplasty implants.

MicroPort Orthopedics’ medial-pivot knee systems stand on more than 20 years of clinically demonstrated history with a complete portfolio of medial-pivot design knees. The Advance® Medial-Pivot knee system was built on the latest kinematic evidence of the natural stability and motion of the knee.1 Its innovative design is carried on by MicroPort’s latest medial-pivot knee, the Evolution® Medial-Pivot knee system, which also aims to restore function by replicating natural motion and stability, and to address some of the common problems seen with traditional designs, such as anterior knee pain and quadriceps avoidance.

The design and successful clinical heritage of MicroPort Orthopedics’ medial-pivot knee systems sets them apart from the competition. A legacy of 98.8 percent survivorship over 17 years and 95 percent patient satisfaction supports its ability to restore stability and normal kinematics. This helps surgeons achieve favorable, reproducible, and long-lasting outcomes for their patients. 2-5
 
“It’s our goal at MicroPort to develop innovative products and procedures that help providers improve patient outcomes, facilitate fast recovery and a return to normal life activities,” says Irina Timmerman, the Vice President of Regulatory and Clinical Affairs at MicroPort Orthopedics. “This rating from ODEP further validates MicroPort’s medial-pivot knee systems’ ability to produce consistent and long-lasting results.”

REFERENCES

1. George A. Macheras et al. “A long term clinical outcome of the Medial Pivot Knee Arthroplasty System.” The Knee Journal, January 29, 2017.

2. Patient satisfaction at 2 months following total knee replacement using a second generation medial-pivot system: follow-up of 250 consecutive cases. Van Overschelde P et al. Ann Transl Med 2016

3. Pritchett JW. Patients prefer a bicruciate-retaining or the medial pivot total knee prosthesis. J Arthroplasty. 2011;26:224–228.

4. Miyazaki Y et al. Analysis of the Kinematics of Total Knee Prostheses With a Medial Pivot Design. J Arthroplasty. 2011; 26(7):1038-1044.

5. Lamontagne M et al.. Muscle Activity in Total Knee Arthroplasty Patients While Ascending and Descending a Ramp. Orthopaedic Proceedings, 2019. 101-B(SUPP_5): p. 59-59.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”